Anumana™ endeavors to enable early detection of diseases by leveraging Mayo Clinic medical knowledge and expertise in inference science for the development and commercialization of digital sensor diagnostics. Utilizing cutting-edge AI and translational science, we aim to interpret the electrocardiogram (ECG) in a novel way, identifying it as a powerful predictive tool and disease biomarker, thereby empowering healthcare providers to assist patients proactively, prior to life-threatening incidents.
Anumana
Headquarters
United States of America